Showing results (21-30 of 142) with videos related to
Sort By:
Pageof 15
Plos One|January 16, 2013
Class II phosphoinositide 3-kinases contribute to endothelial cells morphogenesisGianpaolo Tibolla, Roberto Piñeiro, Daniela Chiozzotto, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 30, 2010
Key role of phosphoinositide 3-kinase class IB in pancreatic cancerCharlotte E Edling, Federico Selvaggi, Richard Buus, et al.International Journal of Biochemistry and Molecular Biology|October 5, 2011
Class II phosphoinositide 3-kinase C2alpha: what we learned so farSimona Mazza, Tania MaffucciScientific Reports|May 21, 2016
A Small Molecule Inhibitor of PDK1/PLCγ1 Interaction Blocks Breast and Melanoma Cancer Cell InvasionClaudio Raimondi, Veronique Calleja, Riccardo Ferro, et al.The Journal of Biological Chemistry|July 24, 2007
The role of phosphoinositide 3-kinase C2alpha in insulin signalingMarco Falasca, William E Hughes, Veronica Dominguez, et al.Current Pharmaceutical Design|February 20, 2010
PI3K/Akt signalling pathway specific inhibitors: a novel strategy to sensitize cancer cells to anti-cancer drugsMarco FalascaCurrent Topics in Microbiology and Immunology|October 15, 2022
An Overview of Class II Phosphoinositide 3-KinasesEmily Yan Zhi Heng, Tania MaffucciJournal of Experimental & Clinical Cancer Research : CR|May 16, 2019
Preclinical validation of 3-phosphoinositide-dependent protein kinase 1 inhibition in pancreatic cancerAikaterini Emmanouilidi, Chanse A Fyffe, Riccardo Ferro, et al.Cancer Research|December 17, 2008
Phospholipase Cgamma1 is required for metastasis development and progressionGianluca Sala, Francesco Dituri, Claudio Raimondi, et al.Pageof 15